Amplify Weight Loss Drug ... (THNR)
NYSEArca: THNR
· Prix en temps réel · USD
27.73
+0.19 (0.69%)
À la clôture : Aug 27, 2026, 3:59 PM
Amplify Weight Loss Drug & Treatment ETF (THNR) : cours, positions et analyse de l'ETF
0.69% (1D)
| Bid | 27.5 |
| Capitalisation boursière | n/a |
| AUM | 5.07M |
| NAV | 27.82 |
| Bêta | n / A |
| EPS (ttm) | n / A |
| Rapport PE (ttm) | 20.08 |
| Parts en circulation | n / A |
| Date de création | May 20, 2024 |
| Ask | 0 |
| Volume | 9,624 |
| Moy. Volume (20D) | 2,193 |
| Ouverture | 27.80 |
| Clôture précédente | 27.54 |
| Fourchette du jour | 27.41 - 27.55 |
| Intervalle de 52 semaines | 22.63 - 27.80 |
| Positions | n / A |
| Ratio de frais | 0.59% |
À propos de THNR
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies expected to economically benefit from weight loss drug development. The index includes pharmaceutical manufacturers, manufacturers of combination therapies and telehealth providers who provide access to Amylin agonists and analogs or GLP-1 agonists and analogs, including dual GLP-1 agonists and analogs. The fund is non-diversified.
Classe d’actifs Equity
Symbole boursier THNR
Date de création May 20, 2024
Fournisseur Amplify Etfs
Site web Page d’accueil du fonds
Échange NYSEArca
10 principaux titres 61.60% des actifs
| Nom | Symbole | Poids |
|---|---|---|
| Novo Nordisk As Adr | NVO | 9.70% |
| Eli Lilly And Co | LLY | 8.92% |
| Regeneron Pharmaceut... | REGN | 6.03% |
| Cspc Pharmaceutical ... | 1093.HK | 5.52% |
| Arrowhead Pharmaceut... | ARWR | 5.34% |
| Innovent Biologics I... | 1801.HK | 5.34% |
| Amgen Inc | AMGN | 5.25% |
| Abbvie Inc | ABBV | 5.24% |
| Roche Holding Ag Ord... | ROP.SW | 5.20% |
| Merck & Co Inc | MRK | 5.06% |
Dividendes Rendement du dividende 1.49%
| Ex-dividende | Montant | Date de paiement |
|---|---|---|
| Dec 30, 2025 | $0.4130 | n / A |
| Dec 30, 2024 | $0.2200 | n / A |
Page 1 de 2